Which hedge funds own BLRX? BIOLINE RX LIMITED, Q2 2026 13F holders

2 tracked hedge funds disclosed a position in BLRX (BIOLINE RX LIMITED) in their Q2 2026 13F filings, worth $94.0k in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 2 opened a new position this quarter: Renaissance Technologies LLC, Citadel Advisors LLC.

2

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

2

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

0

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$94.0k

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$0

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$94.0k

Combined value

Sum of the holders' reported positions in the security.

0.2%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.